Enantioselective synthesis of dual 5-HT4/5-HT3 serotonergic azanoradamantane SC-52491

Tetrahedron

Volumn 55, Issue 40, 1999, Pages 11787-11802

  Becker, Daniel P ^a   Husa, Robert K ^b   Moormann, Alan E ^a   Villamil, Clara I ^a   Flynn, Daniel L ^c  

^a PFIZER INC   (United States)

^b 3 Westbrook Corporate Center   (United States)

^c AMGEN INC   (United States)

Author keywords

5 HT; 5 hydroxytryptamine; Asymmetric synthesis; Azanoradamantane; Diels Alder; Serotonin

Indexed keywords

AZANORADAMANTANE; CISAPRIDE; SC 52490; SEROTONIN; SEROTONIN 4 AGONIST; SEROTONIN 4 ANTAGONIST; SEROTONIN 4 RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; DRUG RECEPTOR BINDING; DRUG STRUCTURE; DRUG SYNTHESIS; ENANTIOMER; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SEROTONINERGIC SYSTEM; STEREOCHEMISTRY;

EID: 0033215219     PISSN: 00404020     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0040-4020(99)00680-8     Document Type: Article

References (22)

1. Shinkai, I., Pure Appl. Chem. 1997, 69, 453-458.
2. a) Whiting, A., "Asymmetrie Diels-Alder Reactions", in Adv. Asymmetrie Synth; Stephenson, G. Richard, Ed.; Chapman & Hall: London, 1996, pp. 126-145.
3. b) Kagan, H. B.; Riant, O. Chem. Rev. 1992, 92, 1007-1019.
4. c) Helmchen, G.; Karge, R.: Weetman, J. "Asymmetrie Diels-Alder Reactions with Chiral Enoates as Dienophiles", in Modern Synthetic Methods 1986; Scheffold, R., Ed.; Springer-Verlag Berlin Heidelberg, 1986, Vol. 4, pp. 261-306.
5. For the application of asymmetric Diels-Alder reactions in the efficient preparation of pharmaceutically important molecules, see for example: d) Martinelli, M. J. J. Org. Chem. 1990, 55, 5065-73.
6. e) Hansen, M. M.; Bertsch, C. F.; Harkness, A. R.; Huff, B. E.; Hutchison, D. R.; Khau, V. V.; LeTourneau, M. E.; Martinelli, M. J.; Misner, J. W.; Peterson, B. C.; Rieck, J. A.; Sullivan, K. A.; Wright, I. G. J. Org. Chem. 1998, 63, 775-85.
7. a) Flynn, D. L.; Becker, D. P.; Spangler, D. P.; Nosal, R.; Gullikson, G. W.; Moummi, C.; and Yang, D. -C. Bioorg. Med. Chem. Lett. 1992, 2, 1613-8.
8. b) Becker, D. P.; Goldstin, B.; Gullikson, G. W.; Loeffler, R.; Moormann, A.; Moummi, C.; Nosal, R.; Spangler, D.; Villamil, C. I.; Yang, D. -C.; Zabrowski, D. L.; Flynn, D. L. in "Perspectives in Receptor Research", ed. D. Giardina et. al., Pharmacochemistry Library, Vol 24, Eisevier Science B. V.: Amsterdam, 1996, pp. 99-120.
9. Baxter, G. S.; Craig, D. A.; Clarke, D. E.; Naunyn-Schmiedeberg's Arch. Pharmacol. 1991, 343, 439.
10. 3H-GR65630 as the radioligand with male rat cortical tissue. Kilpatrick, G. J.; Jones, B. J.; Tyers, M.B.; Nature, 1987, 330, 746.
11. 2-, and β-adrenergic receptors).
12. Becker, D. P.; Nosal, R.; Zabrowski, D. L.; Flynn, D. L. Tetrahedron 1997, 53, 1-20.
13. Becker, D. P.; Flynn, D. L. Tet. Lett. 1993, 34, 2087-90; Becker, D. P.; Flynn, Tetrahedron 1993, 49, 5047-54.
14. Becker, D. P.; Flynn, D. L. Tet. Lett. 1993, 34, 2087-90; Becker, D. P.; Flynn, Tetrahedron 1993, 49, 5047-54.
15. Maruoka, K.; Saito, S.; Yamamoto, H. J. Am. Chem. Soc. 1992, 114, 1089-90.
16. Meth-Cohn, O. J. Chem. Soc., Chem. Commun. 1986, 695-697.
17. Klunder, A. J. H.; van Gastel, F. J. C.; Zwanenburg, B. Tet. Lett. 1988, 29, 2697-2700.
18. a) Hartmann, H.; Abdel Hady, A. F.; Sartor, K.; Weetman, J.; Helmchen, G. Angew. Chem. 1987, 99, 1188-1189;
19. b) Hartmann, H.; Fattah Abdel Hady, A.; Sartor, K.; Weetman, J.; Helmchen, G. Angew. Chem. Int. Ed. Engl. 1987, 26, 1143-1145.
20. c) Helmchen, G.; Poll, T.; Hartmann, H.; Karge, R. DE 3702084 A1 (1987); CAN 108:111830.
21. d) Helmchen, G.; Goeke, A.; Lauer, G.; Urmann, M.; Fries, J.; Angew. Chem. Int. Ed. Engl. 1990, 29, 1024-5.
22. Lazbin, I. M.; Koser, G. F.; J. Org. Chem. 1986, 51, 2669-71.